Truly scalable AI coaching for Life Sciences, measuring a visit’s likelihood to change prescribing
Pharma sales teams practice doctor visits with a video AI avatar that uses only approved content, and get coached on what to fix each time.
Enterprise B2B licences. Per-seat packages for small field forces; platform fee plus usage-based minutes for large ones.
Reps get too little practice. Roleplay doesn’t scale, feedback depends on who coaches, and knowledge alone doesn’t build skill.
Pharma pilots live. Q4 2026: SOC 2 Type I, EU AI Act readiness. Next: new EU pilots, channel deals, country/cluster rollouts.
Deliberate practice, automated: build from approved materials, roleplay an AI physician, score on one rubric, personalise the next sim.
Generic AI roleplay, pharma enablement suites/LMS, other pharma AI roleplay tools, in-house AI builds, live trainers, manager roleplay.
AI platform: video HCP avatars, MLR-gated scenarios, behaviour-science scoring, per-rep coaching plans, manager dashboards, 42 languages.
We are looking for investors, for introductions to European pharma head offices, where enterprise-wide training decisions are made, and for channel partners in pharma commercial services.
Pharma-native; metrics from behaviour-change science, linked to prescribing; one-time country setup, then sims in clicks; anti-cheat.
Pharma, OTC, animal health, medical device firms with 10+ reps. Buyer: commercial excellence. Champion: training. Users: reps, MSLs, KAMs.
Direct enterprise sales + channel partners, or embedded in partner platforms. Land a 10-20 rep pilot, then country and cluster rollouts.
TAM: EUR 9-10B sales-training market (~10% CAGR). SAM: EUR 1.5B pharma field-force training spend shifting to AI-native platforms.
LinkedIn, Google Search and GEO campaigns; pharma congresses; reference cases; partner co-selling.
